Edition:
India

Health Headlines

Clovis Oncology, execs to pay $20 million to settle SEC charges

U.S. biotechnology company Clovis Oncology Inc and its Chief Executive Patrick Mahaffy and former CFO Erle Mast, will pay more than $20 million to settle charges of misleading investors about the efficacy of a cancer drug, the top U.S. securities regulator said on Tuesday.

GSK grabs new drug development head from Boehringer

GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

Physician burnout taking center stage

(Reuters Health) - The medical establishment may finally be coming to grips with the issue of physician burnout. The evidence: two studies on the topic reported in the latest issue of the Journal of the American Medical Association.

Coke eyes cannabis-infused drink market

Coca-Cola Co is closely watching the fast-growing marijuana drinks market for a possible entry that would expand the world's largest soft drink maker's ambitions further away from sugary sodas.

Top News Video

Top News